ES2587055T3 - Una nueva molécula asociada a tumores humanos metastásicos, métodos para detectar tanto el gen activado como la proteína y para interferir con la expresión génica - Google Patents

Una nueva molécula asociada a tumores humanos metastásicos, métodos para detectar tanto el gen activado como la proteína y para interferir con la expresión génica Download PDF

Info

Publication number
ES2587055T3
ES2587055T3 ES09703627.1T ES09703627T ES2587055T3 ES 2587055 T3 ES2587055 T3 ES 2587055T3 ES 09703627 T ES09703627 T ES 09703627T ES 2587055 T3 ES2587055 T3 ES 2587055T3
Authority
ES
Spain
Prior art keywords
seq
tucap
cells
protein
antibody
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES09703627.1T
Other languages
English (en)
Spanish (es)
Inventor
Francesco Lozupone
Stefano Fais
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hansabiomed OU
Original Assignee
Hansabiomed OU
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hansabiomed OU filed Critical Hansabiomed OU
Application granted granted Critical
Publication of ES2587055T3 publication Critical patent/ES2587055T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5758—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
ES09703627.1T 2008-01-25 2009-01-26 Una nueva molécula asociada a tumores humanos metastásicos, métodos para detectar tanto el gen activado como la proteína y para interferir con la expresión génica Active ES2587055T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US6245308P 2008-01-25 2008-01-25
US62453P 2008-01-25
PCT/EE2009/000001 WO2009092385A1 (en) 2008-01-25 2009-01-26 A new metastatic human tumor associated molecule, methods to detect both activated gene and protein and to interfere with gene expression

Publications (1)

Publication Number Publication Date
ES2587055T3 true ES2587055T3 (es) 2016-10-20

Family

ID=40527972

Family Applications (1)

Application Number Title Priority Date Filing Date
ES09703627.1T Active ES2587055T3 (es) 2008-01-25 2009-01-26 Una nueva molécula asociada a tumores humanos metastásicos, métodos para detectar tanto el gen activado como la proteína y para interferir con la expresión génica

Country Status (12)

Country Link
US (1) US8097407B2 (enExample)
EP (1) EP2245465B1 (enExample)
JP (1) JP5752419B2 (enExample)
CN (1) CN102016587B (enExample)
AU (1) AU2009207926B2 (enExample)
BR (1) BRPI0906681A2 (enExample)
CA (1) CA2713193C (enExample)
ES (1) ES2587055T3 (enExample)
MX (1) MX2010008163A (enExample)
PL (1) PL2245465T3 (enExample)
RU (1) RU2546000C2 (enExample)
WO (1) WO2009092385A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120122118A1 (en) * 2008-01-25 2012-05-17 Primm Srl Monclonal antibodies, hybridomas and methods for use
JP2013502217A (ja) * 2009-08-17 2013-01-24 ノックス テクノロジーズ インコーポレイテッド ａｒＮＯＸタンパク質９回膜貫通型スーパーファミリー（ＴＭ９ＳＦ）のクローニング及び発現、方法並びに利用
JP6187939B2 (ja) * 2012-03-08 2017-08-30 学校法人産業医科大学 がんの悪性度の試験方法、ならびに多能性を有する造腫瘍細胞およびその調製方法
WO2015185730A2 (en) * 2014-06-06 2015-12-10 Hansabiomed Ou Exosomal biomarkers
CN105675378A (zh) * 2014-11-18 2016-06-15 上海张江转化医学研发中心有限公司 一种简单的分离单个循环肿瘤细胞的方法和装置
US12105085B2 (en) 2017-05-29 2024-10-01 National University Corporation Kobe University Base material for manufacturing sensor for analyzing detection target, sensor for analyzing detection target, method for analyzing detection target

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030175787A1 (en) * 1997-10-28 2003-09-18 Incyte Corporation Vesicle membrane proteins
WO2000008056A1 (fr) * 1998-08-07 2000-02-17 Ono Pharmaceutical Co., Ltd. NOUVEAU POLYPEPTIDE, ADNc LE CODANT ET SON UTILISATION
US20030008356A1 (en) * 1998-08-07 2003-01-09 Ono Pharmaceutical Co., Ltd. Novel polypeptide, a cDNA encoding the same, and use of it
CA2500687A1 (en) * 2002-10-02 2004-04-15 Genentech, Inc. Compositions and methods for the diagnosis and treatment of tumor
US20080299042A1 (en) * 2004-04-30 2008-12-04 Biogen Idec Ma Inc. Membrane Associated Molecules
WO2006110593A2 (en) * 2005-04-07 2006-10-19 Macrogenics, Inc. Biological targets for the diagnosis, treatment and prevention of cancer

Also Published As

Publication number Publication date
CA2713193A1 (en) 2009-07-30
US8097407B2 (en) 2012-01-17
AU2009207926B2 (en) 2014-06-19
CN102016587A (zh) 2011-04-13
WO2009092385A1 (en) 2009-07-30
BRPI0906681A2 (pt) 2019-11-26
RU2546000C2 (ru) 2015-04-10
MX2010008163A (es) 2011-04-26
EP2245465B1 (en) 2016-05-18
PL2245465T3 (pl) 2016-11-30
CA2713193C (en) 2018-01-02
CN102016587B (zh) 2015-05-13
JP2011511625A (ja) 2011-04-14
RU2010135525A (ru) 2012-02-27
EP2245465A1 (en) 2010-11-03
AU2009207926A1 (en) 2009-07-30
US20090191222A1 (en) 2009-07-30
JP5752419B2 (ja) 2015-07-22

Similar Documents

Publication Publication Date Title
ES2664386T3 (es) Identificación de antígenos asociados a tumor para el diagnóstico y la terapia
US20030096285A1 (en) Identifying anti-tumor targets or agents by lipid raft immunization and proteomics
EP2210092A2 (en) Compositions comprising semaphorins for the treatment of angiogenesis related diseases and methods of selection thereof
US8188051B2 (en) Metadherin polypeptides, encoding nucleic acids and methods of use
Pesapane et al. Recent advances in the function of the 67 kDa laminin receptor and its targeting for personalized therapy in cancer
CA2713193C (en) A metastatic human tumor associated molecule, methods to detect both activated gene and protein and to interfere with gene expression
US20160195538A1 (en) Compositions and methods for detecting, diagnosing, and treating cancer
KR20050103474A (ko) 갈렉틴 9 함유 의약
ES2678049T3 (es) Anticuerpos monoclonales de unión a mcm5
JP2011530283A (ja) がんの診断および治療のためのｖｈｚ
KR20120095301A (ko) 항-사이토케라틴 8/18 복합체 자가면역항체를 포함하는 암 진단 마커 및 이의 항원을 포함하는 암 진단용 조성물
US10145849B2 (en) Monoclonal antibody against necrosis marker PRDX4 and use thereof
WO2012015836A1 (en) Highly potent peptides to control cancer and neurodegenerative diseases
US10189881B2 (en) MPS peptides and use thereof
WO2013163431A1 (en) Diagnosis and treatment of brain tumor
US20120122118A1 (en) Monclonal antibodies, hybridomas and methods for use
US20100286243A1 (en) Mig-7 as a specific anticancer target